Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Elevance Health Inc (NYSE: ELV) closed at $437.77 down -0.77% from its previous closing price of $441.17. In other words, the price has decreased by -$0.77 from its previous closing price. On the day, 1.08 million shares were traded. ELV stock price reached its highest trading level at $440.73 during the session, while it also had its lowest trading level at $434.48.
Ratios:
For a deeper understanding of Elevance Health Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.72.
On March 17, 2025, Argus Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $450.
Stephens Downgraded its Overweight to Equal-Weight on January 22, 2025, whereas the target price for the stock was revised from $520 to $440.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 10 ’25 when Penczek Ronald W sold 443 shares for $415.13 per share. The transaction valued at 183,903 led to the insider holds 1,847 shares of the business.
Penczek Ronald W bought 443 shares of ELV for $183,904 on Mar 10 ’25. On Mar 05 ’25, another insider, Kendrick Charles Morgan JR, who serves as the EVP & President, Commercial of the company, sold 3,504 shares for $396.30 each. As a result, the insider received 1,388,635 and left with 10,116 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELV now has a Market Capitalization of 99105439744 and an Enterprise Value of 97000824832. As of this moment, Elevance’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.09, and their Forward P/E ratio for the next fiscal year is 11.19. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.56 while its Price-to-Book (P/B) ratio in mrq is 2.41. Its current Enterprise Value per Revenue stands at 0.549 whereas that against EBITDA is 9.842.
Stock Price History:
The Beta on a monthly basis for ELV is 0.65, which has changed by -0.13989037 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, ELV has reached a high of $567.26, while it has fallen to a 52-week low of $362.21. The 50-Day Moving Average of the stock is 5.93%, while the 200-Day Moving Average is calculated to be -3.14%.
Shares Statistics:
For the past three months, ELV has traded an average of 1.74M shares per day and 2198850 over the past ten days. A total of 227.48M shares are outstanding, with a floating share count of 225.94M. Insiders hold about 0.20% of the company’s shares, while institutions hold 93.25% stake in the company. Shares short for ELV as of 1743379200 were 2745373 with a Short Ratio of 1.58, compared to 1740700800 on 2479317. Therefore, it implies a Short% of Shares Outstanding of 2745373 and a Short% of Float of 1.21.
Dividends & Splits
According to the company, the forward annual dividend rate for ELV is 6.60, from 6.52 in the trailing year. Against a Trailing Annual Dividend Yield of 0.014778883The stock’s 5-year Average Dividend Yield is 1.18. The current Payout Ratio is 25.39% for ELV, which recently paid a dividend on 2025-03-10 with an ex-dividend date of 1741564800. Stock splits for the company last occurred on 2005-06-01 when the company split stock in a 2:1 ratio.
